Richard Berry had tried nearly everything to fight his prostate cancer: surgery, radiation and chemotherapy. But after two years of treatment, his cancer had metastasized. The opportunity to participate in a clinical trial was his last hope. “I wasn’t ready to die,” Berry, 75, of Keene, NH, tells The Post. “I didn’t want to mess around.”